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Abstract
Background: Malaria in pregnancy is prevalent in Sub-Saharan Africa. The first trimester of pregnancy is a critical
period and the best preventive measure is Long Lasting Insecticidal Nets (LLIN). Unfortunately, few studies have
been conducted which focuses on the usage and efficacy of LLIN on malaria prevention during the first trimester.
Methods: We assessed the use and effectiveness of LLIN in early pregnancy in Benin and its impact on malaria
infection risk. We followed-up a cohort of 240 pregnant women from pre-conception to the end of the first
trimester of pregnancy in Southern Benin. Parasitological, maternal and LLIN data were actively collected before, at
the beginning and end of the first trimester of pregnancy. A Cox regression model was used to determine the
relationship between the time to onset of the first malaria infection and the use, physical integrity, and bio-efficacy
of the LLIN, adjusted for relevant covariables.
Results: The good use, good physical integrity and biological efficacy of LLIN were associated with a decreased risk of
occurrence of the first malaria infection in early pregnancy (HRa = 0.38; (0.18–0.80); p < 0.001; HRa = 0.59; (0.29–1.19); p
< 0.07; HRa = 0.97; (0.94–1.00); p < 0.04 respectively), after adjustment for other covariates. Primi/secundigravidity and
malaria infection before pregnancy were associated with a risk of earlier onset of malaria infection.
Conclusion: The classically used LLIN’s indicators of possession and use may not be sufficient to characterize the true
protection of pregnant women in the first trimester of pregnancy. Indicators of physical integrity and bio-efficacy
should be integrated with those indicators in evaluation studies.
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Background
Malaria in pregnancy results in an increased risk of low
birth weight (LBW) [1–3], maternal anemia and perinatal
mortality [1, 4]. World Health Organization (WHO) has
implemented a prevention policy specific to this vulnerable
population [5, 6], based on sulfadoxine-pyrimethamine (SP)
intermittent preventive treatment in pregnant women
(IPTp) and the use of Long Lasting Impregnated Nets
(LLIN) from the onset of pregnancy. The IPTp comprises
monthly intakes of a curative dose of SP during antenatal
care visits from the second trimester of pregnancy for all
pregnant women (whether infected or not). Numerous
studies have shown the effectiveness of IPTp in improving
maternal and child health outcomes [7–10]. However, IPTp
is contraindicated in the first trimester of pregnancy leaving
women in the first trimester unprotected by this control
tool. Moreover, several studies have shown that the first tri-
mester of pregnancy is a critical period during which mal-
aria infection is associated with an increased risk of low
birth weight and maternal anemia [11–13]. LLIN is the only
preventive tool available for pregnant women during this
period. However, it is known that pregnant women attend
the maternity clinic mostly after the first trimester of preg-
nancy in sub-Saharan Africa [14]. Consequently, the first
trimester of pregnancy is a period badly covered by the
malaria prevention policy. There is evidence for the efficacy
of LLIN in preventing malaria infection during pregnancy
[15], to improve babies’ birth weight [16]. No study has yet
focused on the specific protection conferred by LLIN in the
first trimester of pregnancy. In this work, using data from
the follow-up of a pre-conceptional cohort carried out in
South-Benin in 2015–1016, we evaluated the association
between the indicators of use, physical integrity and
bio-efficacy of LLINs used by pregnant women and malaria
incidence during the first trimester of pregnancy.
Methods
Study design
EVALMOUS is a cohort study nested in the RECIPAL
project, carried out in South Benin [17]. Between June
2014 and August 2017, 1214 women of childbearing age
and willing to become pregnant (primary cohort) were in-
cluded in a cohort follow-up. All women were screened
for malaria using thick blood smear (TBS) at their inclu-
sion and monitored monthly using a urinary pregnancy
test until the identification of 411 pregnant women among
them (secondary cohort). The pregnant women were then
monitored monthly until delivery at the maternity clinic,
where they benefited from a clinical, parasitological (by
TBS), nutritional and ultrasound follow-up. Lambarene
technique was used to quantify parasitaemia and the de-
tection threshold with this method has been estimated to
be 5 parasites/μL [18]. In addition, in the event of fever or
symptoms suggestive to malaria, pregnant women were
screened using Rapid Diagnostic Tests (RDT) and treated
with Artemisinin-based Combination Therapies (ACT)
when tested positive for malaria according to the national
guidelines [19].
EVALMOUS study held between 1st June 2015 and 31st
October 2016 and aimed to assess the effectiveness of
mosquito nets used by pregnant women and other mem-
bers of their household in preventing malaria. The first
576 women from the RECIPAL primary cohort who
agreed to participate were included in EVALMOUS study
before their pregnancy and the first 240 of them to be-
come pregnant were followed throughout the first trimes-
ter of pregnancy. Women were visited at three home
visits: a first visit was performed before pregnancy and
two visits during the first trimester of pregnancy. During
these visits, a questionnaire was administered to the
women in order to evaluate the indicators related to LLIN,
namely: possession, use and physical integrity. At the last
visit the mosquito net used by the pregnant women was
taken for laboratory testing to assess their bio-efficacy and
replaced by new ones provided by the study. Physical in-
tegrity and bio-efficacy of the LLINs were determined by
the field workers using the standard WHO protocol [20].
Variables
Outcome variable
Malaria infection during the first trimester of pregnancy
was defined as a positive blood smear and/or a positive
RDT before 15 weeks of gestation (estimated by early
ultrasound scan). Timing of malaria infection was deter-
mined based on gestational age.
Independent variables
At each visit during the study (before pregnancy and dur-
ing the first trimester of pregnancy), the use of mosquito
net was defined as a binary variable, “good” if LLIN was
reported to be used every day of the week preceding the
visit and if it was properly installed after inspection by the
investigator.
The physical integrity of nets was characterized by a
hole index (hi) resulting from the characterization of the
holes according to WHO protocol [20]. A mosquito net
with a hi between 0 and 64 was considered as in “good”
condition, a hi between 65 and 642 as in an “acceptable”
state and a hi greater than 643 as in a “bad” state.
Bio-efficacy of LLIN was based on both kd60 (knock--
down 60 min) and 24 h-death (mortality after 24 h) of
female Anopheles gambiae “Kisumu strain” 2–5 days
after exposure to LLIN through standard WHO cone. A
LLIN was declared bio-effective when the kd60 rate
induced by this LLIN is greater than or equal to 95% or
when the mortality rate induced by it is greater than or
equal to 80% [20].
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Statistical analysis
First, we did a descriptive analysis of the general charac-
teristic of the women at baseline (sociodemographic, the
characteristics of the LLINs and the malaria before
pregnancy).
Univariable analysis
We studied the relationship between the time to onset
of the first malaria infection in the first trimester of
pregnancy and each of the independent variables by a
univariable Cox regression model. For each covariate,
the proportional risk hypothesis was verified using the
overall “p” of the Schoenfeld residue-based test. For the
continuous covariates, the linearity hypothesis was veri-
fied. The comparison between the Kaplan-Meier curves
of the different categories of qualitative variables was
carried out by a log rank test.
Multivariable analysis
The malaria infection and the LLINs indicators were
available for 190 pregnant women out of the 240. We
compared the 190 pregnant women included in the mul-
tivariable analysis and the 50 excluded women according
to the age (t-test), the gestational rank, the residence
area and the malaria infection before pregnancy. The
comparison of the age in the two groups was performed
by a t-test whereas the categorical variables were com-
pared using a Chi2 test.
A multivariable Cox regression model was used. Adjust-
ment factors were age (in years) of the pregnant women
(quantitative variable recoded in quartiles); the gestational
rank (less than 3 pregnancies/more than 3 pregnancies;
marital status (unmarried/married); pre-pregnancy mal-
aria infection during the pre-pregnancy visit; ethnicity
(Toffin/other); level of education (literate/illiterate); occu-
pational status (employed/unemployed) and residential
area (lake area/land area).
First, all covariates were introduced in the model and a
backward step-by-step strategy was performed to eliminate
non-significant cofactors. At the end of the analysis, only
the cofactors associated with the variable to be explained at
the 5% p-value threshold were retained in the final model
in addition to the LLIN indicator variables. As we consid-
ered in this study one-sided alternative hypotheses (i.e. bet-
ter use, better physical integrity and better bio-efficacy
would confer protection against malaria), we used
one-sided p-values with a threshold of significance at 5%.
During the study, six pregnant women had at least 2
malaria infections during the first trimester of preg-
nancy. In order to assess the determinants of the num-
ber of infections, we performed a multivariable Poisson
regression model, regressing the same covariates (as in
the Cox model) on the number of infections in the first
trimester. In addition, in order to take into account the
different number of measures between the women, an
offset (the log of the number of visits) has been intro-
duced in the model.
The analyses were carried out with STATA software
version 13.1 (STATA Corporation, Texas).
Results
Five hundred and seventy-six pregnant women were
included in the EVALMOUS study. Figure 1 shows the
flow chart during follow-up of these women. We
included 240 pregnant women. At the end of the eight-
een months of follow-up, the proportion of drop-out,
miscarriages, and refusals was 0.42%; 8.33 and 5% re-
spectively. The bioassays were carried out in the labora-
tory on 324 LLINs at the end of the first trimester.
The characteristics of the pregnant women included in
the study are shown in Table 1. Among the 240 women,
the prevalence of malaria infection before pregnancy was
4.41% and the proportion of infected pregnant women
during the first trimester of pregnancy was 18.33%. All
women except one had an LLIN.
During pregnancy, all but one of the women had
LLINs. Most of pregnant women (83.25%) had used their
LLIN properly during the week prior to the visits. About
60% of the LLINs inspected were in good physical condi-
tion. On the other hand barely 6% of LLINs tested in the
laboratory were bio-effective. Table 2 recapitulates the
characteristics of the LLIN’s indicators inspected.
Table 3 shows the different proportions of malaria in-
fection during the different visits of the first trimester of
pregnancy. The median time between onset of malaria
before pregnancy and the beginning of pregnancy was
7.6 months with an interquartile range of (4.9–8.5).
Figure 2 shows the probability of non-occurrence of
malaria infection in pregnant women as a function of
time during the first trimester of pregnancy. The inci-
dence rate of malaria infections was 7.18 cases per 100
person-months (95% CI: 5.36–9.62).
The group of women not included in the multivariate
analysis did not differ significantly from the included
pregnant women, according to the 4 variables: age, resi-
dence area, gestational rank and malaria before preg-
nancy (respective p-values = 0.48; 0.29; 0.24 and 0.58
respectively). Based on those results, excluding the 50
women from the multivariable model does not seem to
have led to a major selection bias.
The variables selected in the final multivariate model
respected the proportional hazard asumption assump-
tion according to the Schöenfeld residuals method.
Additional file 1: Table S1 and Table 4 respectively
summarize the univariate Cox regression model and the
final multivariate Cox model. After adjustment, the use
of LLIN by pregnant women was marginally significant,
whereas the physical integrity, the LLIN’s quantitative
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bio-efficacy and malaria infection in pre-pregnancy were
significantly associated with the time to onset of the first
malaria infection in the first trimester of pregnancy.
We also performed a Poisson model to study the effect of
the three indicators of LLIN on the number of malaria in-
fections occurring during the first trimester of pregnancy
adjusted for the same covariates. In this analysis
(Additional file 2: Table S2), the three indicators of the
LLINs (the use, the physical integrity and the quantitative
bio-efficacy) were significantly associated with the incidence
of malaria infection during the first trimester of pregnancy,
(IRRa = 0.40; (0.20–0.78); p < 0.003; IRRa = 0.44; (0.24–
0.81); p < 0.004; IRRa = 0.98; (0.95–0.99); p < 0.02 respect-
ively), confirming the results of the Cox model.
Discussion
The peculiarity of our study was the ability to have
followed the women from the pre-conceptional period
until the end of the first trimester of pregnancy. This
study identified two sets of essential results, i) the re-
fined characterization of the protection given to the
pregnant women by the LLIN against malaria infection
during the first trimester of pregnancy and ii) new im-
portant elements in the reflection on the different indi-
cators of LLIN’s efficiency that characterize properly the
real protection of pregnant women against malaria dur-
ing this critical period.
We observed a general high possession and good use
of LLIN by the study pregnant women. This is probably
an indication of the success of the LLIN mass distribu-
tion campaigns carried out previously in Benin in 2011
and 2014. In all, the Cox model confirmed our working
hypothesis that the different indicators were significantly
related to the delay in malaria infection. Precisely, good
Fig. 1 Flow chart of EVALMOUS study, Benin 2015–2016
Table 1 Characteristics of pregnant women at the inclusion,
Sô-Ava and Akassato, Benin 2015–2016 (N = 240)
Characteristics Pre-pregnancy
Total Mean or proportion
(95% CI)
Age (years) 240 26.61 ± 4.78
Gestational rank 240
Primigravida 22 9.17 (5.49; 12.84)
Secundigravida 36 15.00 (10.45; 19.55)
Multigravida 182 75.83 (70.38; 81.29)
Ethnic Group 240
Toffin 156 65.00 (58.92; 71.08)
Others 84 35.00 (28.92; 41.08)
Education level 240
Illiterate 161 67.08 (61.09; 73.07)
Literate 79 32.92 (26.93; 38.90)
Occupational status 240
Employed 221 92.08 (88.64; 95.52)
Unemployed 19 7.92 (4.48; 11.36)
Marital status 240
Cohabitation 11 4.58 (1.92; 7.25)
Married (monogamy) 159 66.25 (60.22; 72.27)
Married (polygamy) 70 29.17 (23.37; 34.96)
Residence area 240
Lake area 156 65.00 (58.92; 71.08)
Land area 84 35.00 (28.92; 41.08)
Pre-pregnancy malaria 227
Yes 10 4.41 (1.72; 7.10)
No 217 95.59 (92.90; 98.28)
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use, good physical integrity and the quantitative
bio-efficacy of the LLIN were found to be associated
with a later occurrence of the first malarial infection
during the first trimester of pregnancy. In this model the
physical integrity of the LLIN was associated only mar-
ginally significantly with the delay of the first malaria in-
fection but showed significant associations in the
Poisson regression model. Five pregnant women had
malaria infection twice in our study. Two studies did not
find any association between LLIN usage by pregnant
women and the risk of malaria infection [21, 22]. Since
the effectiveness of LLIN to reduce the malaria burden
has been extensively established [23] including in preg-
nant women [15, 24–28], those result show probably the
limit of the two classical indicators of ownership and re-
ported LLIN use the previous night to characterize ad-
equately the optimal protection of the pregnant woman
against the occurrence of a malaria infection. All these
elements point out the need to consider, in addition to
the classical ownership and reported use indicators, the
physical integrity and bio-efficacy indicators should be
taken into account in evaluation studies of LLIN effi-
ciency to reduce the malaria burden in pregnant women.
In our study, the high proportions of good use and
LLINs with good physical integrity are in favor of a good
physical barrier conferred by LLIN to the pregnant
women during the first trimester of pregnancy. Never-
theless, a more worrying result was the small minority of
Table 2 Indicators of possession, use, physical integrity and chemical efficacy of LLINs inspected during follow-up, Sô-Ava and
Akassato, Benin 2015–2016 (N = 240)
Characteristics Pre-pregnancy Pregnancy visit 1 Pregnancy visit 2
Total Mean or proportion
(95% CI)
Total Mean or proportion
(95% CI)
Total Mean or proportion
(95% CI)
Possession of at least one LLIN/household 240 240 203
Yes 237 98.75 (96.17; 97.60) 239 99.53 (97.06; 99.94) 202 99.51 (96.53; 99.93)
No 3 1.25 (0.40; 3.83) 1 0.42 (0.06; 2.94) 1 0.49 (0.07; 3.47)
Possession of LLIN according to WHO standards (1
LLIN/2 people)
237 239 202
Yes 178 75.11 (69.16; 80.23) 185 77.41 (71.63; 82.30) 164 81.19 (75.14; 86.03)
No 59 24.89 (19.77; 30.84) 54 22.59 (17.70; 28.37) 38 18.81 (13.96; 24.85)
Use of LLIN by pregnant women 237 239 202
Yes 199 83.97 (78.69; 89.13) 203 84.94 (79.78; 88.96) 178 88.12 (82.83; 91.93)
No 38 16.03 (11.86; 21.31) 36 15.06 (11.04; 20.22) 24 11.88 (8.06; 17.17)
Physical integrity of pregnant woman’s LLIN 237 239 202
Good 156 65.82 (59.51; 71.62) 145 60.67 (54.29; 66.70) 115 56.93 (49.95; 63.64)
Bad 81 34.18 (28.38; 40.49) 94 39.33 (33.30; 45.71) 87 43.07 (36.36; 50.05)
Physical integrity of household’s LLIN 169 195 164
Good 101 59.76 (52.12; 66.96) 117 60.00 (52.91; 66.70) 96 58.54 (50.77; 77.90)
Bad 68 40.24 (33.04; 47.88) 78 40.00 (33.30; 47.09) 68 41.46 (34.10; 49.23)
Bio-efficacy of pregnant women’s LLIN 198
Yes – – 12 6.06 (3.46; 10.41)
No – – 186
Bio-efficacy of household’s LLIN 126
Yes – – 7 5.56 (2.64; 11.30)
No – – 119 94.44 (88.70; 97.36)
Table 3 Proportion of pregnant women infected during the first trimester of pregnancy, Sô-Ava and Akassato, Benin 2015–2016
Malaria
infection
Pre-pregnancy visit Visit 1 Visit 2 Visit 3
n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
Total 227 234 199 180
Yes 10 4.41 (2.37; 8.03) 14 5.98 (3.56; 9.88) 10 5.02 (2.71; 9.13) 17 9.44 (5.92; 14.73)
A total of 239 pregnant women were followed during 626.63 person-months, with a median follow-up time of 88 days (Interquartile interval: 65–95)
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LLIN reaching the bio-efficacy threshold set by the
WHO recommendations. This raises the highly import-
ant question of the duration of the LLINs bio-efficacy in
field conditions. Given that optimal protection by the
LLIN is provided by the combination of its physical bar-
rier and chemical efficacy, we can conclude that the ex-
treme majority of women in the study were not
optimally protected against malaria in the first trimester
of their pregnancy by the LLIN they used. This import-
ant conclusion would have been missed if only based on
the ownership and usage classical indicators.
A strength of our study is that for the first time in a mal-
aria cohort, the women were seen at a pre-conceptional
stage which allowed to follow them on the very beginning
of their pregnancy. This is an important strenght compared
to non preconcepional studies. Although our results indi-
cate minimal selection bias, the moderate size of our sam-
ple and the particular facies of the study area (lake zone)
impose some caution on the representativeness of the
results.
Conclusion
Our study demonstrated for the first time an overall
good physical protection against the malaria vector con-
ferred by LLIN in pregnant women in their first trimes-
ter of pregnancy, but low chemical protection in our
study area. An important conclusion is that, in addition
to the traditional indicator of possession of LLINs by
pregnant women, it is essential to take into account
other indicators such as actual use, physical integrity
and bio-efficiency of LLIN, since all these indicators re-
flect independently from each other the real protection
against malaria of this population. Further studies are
then needed to assess the generalizability of our results
and also to control the duration of the chemical effect-
iveness of the LLIN distributed on the territory.
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